IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v44y2021i3d10.1007_s40264-020-01030-2.html
   My bibliography  Save this article

Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices

Author

Listed:
  • Kristof Huysentruyt

    (Patient Safety, UCB)

  • Oeystein Kjoersvik

    (R&D IT, MSD)

  • Pawel Dobracki

    (Roche Polska Sp. z o.o.)

  • Elizabeth Savage

    (Global Medical Organization, Janssen Research & Development, LLC a division of Johnson & Johnson)

  • Ellen Mishalov

    (Astellas)

  • Mark Cherry

    (Information Technology, AstraZeneca)

  • Eileen Leonard

    (Bristol-Myers Squibb Company)

  • Robert Taylor

    (Global Regulatory Affairs and, Merck & Co., Inc.)

  • Bhavin Patel

    (Pfizer Inc)

  • Danielle Abatemarco

    (Bristol-Myers Squibb Company)

Abstract

Pharmacovigilance is the science of monitoring the effects of medicinal products to identify and evaluate potential adverse reactions and provide necessary and timely risk mitigation measures. Intelligent automation technologies have a strong potential to automate routine work and to balance resource use across safety risk management and other pharmacovigilance activities. While emerging technologies such as artificial intelligence (AI) show great promise for improving pharmacovigilance with their capability to learn based on data inputs, existing validation guidelines should be augmented to verify intelligent automation systems. While the underlying validation requirements largely remain the same, additional activities tailored to intelligent automation are needed to document evidence that the system is fit for purpose. We propose three categories of intelligent automation systems, ranging from rule-based systems to dynamic AI-based systems, and each category needs a unique validation approach. We expand on the existing good automated manufacturing practices, which outline a risk-based approach to artificially intelligent static systems. Our framework provides pharmacovigilance professionals with the knowledge to lead technology implementations within their organizations with considerations given to the building, implementation, validation, and maintenance of assistive technology systems. Successful pharmacovigilance professionals will play an increasingly active role in bridging the gap between business operations and technical advancements to ensure inspection readiness and compliance with global regulatory authorities.

Suggested Citation

  • Kristof Huysentruyt & Oeystein Kjoersvik & Pawel Dobracki & Elizabeth Savage & Ellen Mishalov & Mark Cherry & Eileen Leonard & Robert Taylor & Bhavin Patel & Danielle Abatemarco, 2021. "Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices," Drug Safety, Springer, vol. 44(3), pages 261-272, March.
    • Handle: RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01030-2
    DOI: 10.1007/s40264-020-01030-2
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-020-01030-2
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-020-01030-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Karolina Danysz & Salvatore Cicirello & Edward Mingle & Bruno Assuncao & Niki Tetarenko & Ruta Mockute & Danielle Abatemarco & Mark Widdowson & Sameen Desai, 2019. "Artificial Intelligence and the Future of the Drug Safety Professional," Drug Safety, Springer, vol. 42(4), pages 491-497, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Barenji, Reza Vatankhah & Hariry, Reza Ebrahimi & Demirkol, Denizhan & Daim, Tugrul U., 2024. "Research landscape analysis for quality in Pharma 4.0 era," Technology in Society, Elsevier, vol. 76(C).
    2. Oeystein Kjoersvik & Andrew Bate, 2022. "Black Swan Events and Intelligent Automation for Routine Safety Surveillance," Drug Safety, Springer, vol. 45(5), pages 419-427, May.
    3. Ghobakhloo, Morteza & Asadi, Shahla & Iranmanesh, Mohammad & Foroughi, Behzad & Mubarak, Muhammad Faraz & Yadegaridehkordi, Elaheh, 2023. "Intelligent automation implementation and corporate sustainability performance: The enabling role of corporate social responsibility strategy," Technology in Society, Elsevier, vol. 74(C).

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Oeystein Kjoersvik & Andrew Bate, 2022. "Black Swan Events and Intelligent Automation for Routine Safety Surveillance," Drug Safety, Springer, vol. 45(5), pages 419-427, May.
    2. Andrew Bate & Steve F. Hobbiger, 2021. "Artificial Intelligence, Real-World Automation and the Safety of Medicines," Drug Safety, Springer, vol. 44(2), pages 125-132, February.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01030-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.